Bioeq GmbH

A Formycon Group Company

Since the acquisition in May 2022, Bioeq GmbH is a part of the Formycon Group and continues to be the sponsor of the ongoing clinical trials for Formycon’s biosimilar candidates.

The former Bioeq employees have meanwhile joined #TeamFormycon and contribute their expertise in clinical development, regulatory affairs, business development, commercial affairs, IP as well as project management to Formycon’s strengthened development organization.

More about the Formycon Group

Bioeq GmbH · Germany ·